Profile data is unavailable for this security.
About the company
IMCD NV is a company based in the Netherlands that specializes in sales, marketing and distribution of specialty chemicals and foods ingredients. Its product portfolio includes chemicals from various areas, including pharmaceutics, personal care, coatings, food and nutrition, lubricants, synthesis, plastics, detergents, agrochemicals, textile, waste and water treatment, cutting and sand blasting, flavors and fragrances, oil and gas and polishing, among others. The Company operates an international supply chain with local warehouses and provides valued-added services, including repacking, dilution and blending. The Company operates worldwide.
- Revenue in EUR (TTM)4.78bn
- Net income in EUR217.58m
- Incorporated1995
- Employees5.25k
- LocationIMCD NVWilhelminaplein 32ROTTERDAM 3072 DENetherlandsNLD
- Phone+31 102908684
- Fax+31 102908680
- Websitehttps://www.imcdgroup.com/
More ▼
Mergers & acquisitions
| Acquired company | IMCD:AEX since announced | Transaction value |
|---|---|---|
| Tillmanns SpA | -13.94% | -- |
| Apus Quimica SpA | -29.71% | -- |
| Trichem Healthcare Pvt Ltd | -27.55% | -- |
| Ferrer Alimentacion SA | -30.34% | -- |
| Medir Ferrer y Cia SA | -30.34% | -- |
Data delayed at least 15 minutes, as of Feb 27 2026 16:39 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corbion NV | 1.27bn | 74.80m | 1.13bn | 2.41k | 15.10 | 1.51 | 7.06 | 0.8949 | 1.29 | 1.29 | 21.86 | 12.89 | 0.8554 | 3.74 | 7.29 | 526,328.90 | 5.05 | 4.41 | 6.74 | 6.25 | 26.41 | 24.16 | 5.90 | 5.23 | 1.11 | 5.95 | 0.3756 | 51.92 | -1.61 | 5.14 | 62.96 | 0.4609 | -5.16 | 12.30 |
| Solvac SA | 132.44m | 125.93m | 1.47bn | 0.00 | 11.71 | 0.5861 | 51.36 | 11.14 | 5.89 | 5.89 | 6.20 | 117.73 | 0.0479 | -- | 939.26 | -- | 4.55 | 2.33 | 4.71 | 2.39 | -- | -- | 95.09 | 91.21 | -- | 38.99 | 0.0563 | 180.86 | -17.76 | 24.62 | -17.78 | 26.75 | -- | 1.32 |
| Tessenderlo Group NV | 2.75bn | -27.10m | 1.59bn | 7.23k | -- | 0.9045 | 8.50 | 0.5786 | -0.4469 | -0.4469 | 45.37 | 29.74 | 0.9568 | 4.20 | 5.28 | 379,753.80 | -0.9234 | 5.69 | -1.17 | 7.15 | 19.33 | 23.10 | -0.965 | 5.61 | 1.18 | 1.83 | 0.1254 | 26.02 | -9.58 | 8.72 | -60.91 | -14.94 | 11.61 | -- |
| Solvay SA | 4.75bn | 29.00m | 2.93bn | 8.40k | 104.58 | 2.84 | 7.06 | 0.6185 | 0.265 | 0.265 | 45.06 | 9.76 | 0.7387 | 6.19 | 6.55 | 564,880.90 | 0.5604 | 4.80 | 0.8012 | 6.48 | 21.14 | 24.16 | 0.7587 | 7.28 | 0.8504 | 9.38 | 0.6673 | 39.37 | -7.49 | -13.35 | -86.55 | -- | -16.28 | -8.31 |
| Umicore SA | 19.37bn | 384.50m | 4.44bn | 11.23k | 11.26 | 1.94 | 6.76 | 0.2292 | 1.60 | 1.60 | 80.70 | 9.31 | 2.05 | 7.35 | 13.69 | 1,725,209.00 | 4.13 | 0.9201 | 7.60 | 1.57 | 8.74 | 7.21 | 2.01 | 0.4264 | 0.7476 | 6.16 | 0.5558 | 119.65 | 30.43 | -1.32 | 125.98 | 24.12 | -5.70 | -7.79 |
| Imcd NV | 4.78bn | 217.58m | 4.81bn | 5.25k | 22.09 | 2.35 | 13.35 | 1.01 | 3.68 | 3.68 | 80.93 | 34.57 | 1.00 | 5.24 | 5.71 | 910,955.80 | 4.57 | 6.67 | 5.85 | 8.82 | 21.82 | 22.08 | 4.55 | 5.95 | 1.06 | 4.25 | 0.4671 | 38.23 | 1.08 | 11.48 | -21.80 | 12.61 | 2.38 | 12.15 |
| Syensqo NV | 6.26bn | -78.00m | 5.03bn | 13.28k | -- | 0.8147 | 8.15 | 0.8031 | -0.7739 | -0.6171 | 60.85 | 59.37 | 0.5243 | 3.71 | 7.21 | -- | -0.6366 | 2.42 | -0.7493 | 3.38 | 30.23 | 32.11 | -1.21 | 4.47 | 1.41 | -- | 0.3271 | -- | -12.81 | 2.10 | -1,640.00 | -- | 11.08 | -- |
| Akzo Nobel NV | 10.16bn | 636.00m | 10.20bn | 31.50k | 16.04 | 2.19 | 9.71 | 1.00 | 3.72 | 3.71 | 59.41 | 27.23 | 0.7204 | 3.76 | 4.15 | 322,476.20 | 4.77 | 4.22 | 7.13 | 6.63 | 39.86 | 39.34 | 6.62 | 5.77 | 1.08 | 11.50 | 0.5021 | 51.61 | -5.16 | 3.56 | 17.34 | -0.0314 | 3.67 | 0.3058 |
Data as of Feb 27 2026. Currency figures normalised to IMCD NV's reporting currency: Euro EUR
34.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Edgepoint Investment Group, Inc.as of 01 Oct 2025 | 3.09m | 5.23% |
| Invesco Asset Management Ltd.as of 06 Feb 2026 | 2.52m | 4.27% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.20m | 3.72% |
| Burgundy Asset Management Ltd.as of 03 Nov 2025 | 2.01m | 3.39% |
| UBS Asset Management (UK) Ltd.as of 19 Feb 2026 | 1.98m | 3.34% |
| Massachusetts Financial Services Co.as of 18 Feb 2026 | 1.81m | 3.07% |
| Harris Associates LPas of 02 Dec 2025 | 1.80m | 3.05% |
| Fidelity Management & Research Co. LLCas of 25 Sep 2025 | 1.76m | 2.97% |
| Marshall Wace LLPas of 27 Aug 2025 | 1.75m | 2.97% |
| Merrill Lynch International (Investment Management)as of 24 Feb 2026 | 1.60m | 2.70% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
